Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 20/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 20/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 20/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7964681 | 1.00 | ADRA1D (0.57) | ADRA1DADRA1AADRA1B | |
| SCHEMBL7164510 | 1.00 | ADRA1D (0.57) | ADRA1DADRA1AADRA1B | |
| SCHEMBL7164513 | 1.00 | ADRA1D (0.57) | ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL7970657 | 0.99 | ADRA1D (0.56) | ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL7970661 | 0.99 | ADRA1D (0.56) | ADRA1DADRA1AADRA1B | |
| SCHEMBL7075799 | 0.92 | ADRA1D (0.68) | ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL7079267 | 0.92 | ADRA1D (0.67) | ADRA1DADRA1AADRA1B | |
| SCHEMBL7077852 | 0.90 | ADRA1D (0.56) | ADRA1DADRA1AADRA1B | |
| SCHEMBL8142307 | 0.90 | ADRA1A (0.71) | ADRA1DADRA1AADRA1B | |
| SCHEMBL8142311 | 0.90 | ADRA1A (0.71) | ADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6255315-B1 | BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2001-07-03 | — | — | US | claimed |
| US-6255315-B1 | BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2001-07-03 | — | — | US | disclosed |
| US-6037354-A | ADMINISTERING PHENYL-SUBSTITUTED THIAZOLIDIN-4-ONE OR OXAZOLIDIN-2-ONE DERIVATIVE TO TREAT BENIGN PROSTATE HYPERPLASIA; SIDE EFFECT REDUCTION | MERCK & CO., INC. (US) | 2000-03-14 | — | — | US | disclosed |